Accounts Receivable (Quarterly) Chart

View Accounts Receivable (Quarterly) for COO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accounts Receivable (Quarterly) Chart
Start Trial

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
April 30, 2026 809.20M
January 31, 2026 807.10M
October 31, 2025 829.00M
July 31, 2025 792.30M
April 30, 2025 780.90M
January 31, 2025 716.40M
October 31, 2024 717.00M
July 31, 2024 739.00M
April 30, 2024 688.70M
January 31, 2024 651.00M
October 31, 2023 609.70M
July 31, 2023 629.90M
April 30, 2023 564.70M
January 31, 2023 581.80M
October 31, 2022 557.80M
July 31, 2022 543.60M
April 30, 2022 532.00M
January 31, 2022 525.90M
October 31, 2021 515.30M
July 31, 2021 535.10M
April 30, 2021 490.10M
January 31, 2021 461.20M
October 31, 2020 435.40M
July 31, 2020 450.50M
April 30, 2020 368.80M
Date Value
January 31, 2020 408.00M
October 31, 2019 435.30M
July 31, 2019 404.70M
April 30, 2019 396.20M
January 31, 2019 389.70M
October 31, 2018 374.70M
July 31, 2018 375.60M
April 30, 2018 432.60M
January 31, 2018 413.80M
October 31, 2017 316.60M
July 31, 2017 335.90M
April 30, 2017 311.20M
January 31, 2017 290.90M
October 31, 2016 291.37M
July 31, 2016 307.34M
April 30, 2016 298.82M
January 31, 2016 278.89M
October 31, 2015 282.92M
July 31, 2015 280.16M
April 30, 2015 267.18M
January 31, 2015 275.90M
October 31, 2014 276.28M
July 31, 2014 261.96M
April 30, 2014 239.77M
January 31, 2014 235.29M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

View Accounts Receivable (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accounts Receivable (Quarterly) Benchmarks

View Accounts Receivable (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 8.21B
Boston Scientific Corp. 3.027B
Solventum Corp. 1.059B
Align Technology, Inc. 1.125B
Innovative Eyewear, Inc. 0.0715M